american healthcare reit inc - AHR
AHR
Close Chg Chg %
48.18 0.61 1.26%
Closed Market
48.79
+0.61 (1.26%)
Volume: 2.32M
Last Updated:
Feb 6, 2026, 3:59 PM EDT
Company Overview: american healthcare reit inc - AHR
AHR Key Data
| Open $48.66 | Day Range 48.11 - 49.52 |
| 52 Week Range 26.48 - 51.02 | Market Cap $8.69B |
| Shares Outstanding 185.51M | Public Float N/A |
| Beta 1.02 | Rev. Per Employee N/A |
| P/E Ratio 342.12 | EPS $0.14 |
| Yield 207.60% | Dividend $0.25 |
| EX-DIVIDEND DATE Dec 31, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 3.47M |
AHR Performance
| 1 Week | 3.97% | ||
| 1 Month | 3.15% | ||
| 3 Months | -1.32% | ||
| 1 Year | 66.45% | ||
| 5 Years | N/A |
AHR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
13
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 56.077 | |
| Number of Ratings | 13 | Current Quarters Estimate | 0.144 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 0.707 | |
| Last Quarter’s Earnings | 0.16 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.512 | Next Fiscal Year Estimate | 0.882 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 5 | 4 |
| Mean Estimate | 0.14 | 0.17 | 0.71 | 0.88 |
| High Estimates | 0.15 | 0.21 | 0.79 | 0.99 |
| Low Estimate | 0.14 | 0.14 | 0.58 | 0.70 |
| Coefficient of Variance | 3.45 | 16.66 | 11.38 | 14.72 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 11 | 11 | 10 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for American Healthcare Reit Inc - AHR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for American Healthcare Reit Inc - AHR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 8, 2025 | Brian S. Peay Chief Financial Officer | 180,074 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Brian S. Peay Chief Financial Officer | 176,637 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 5,438,653.23 |
| Apr 8, 2025 | Brian S. Peay Chief Financial Officer | 6,768 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Danny Prosky CEO & President; Director | 327,968 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Danny Prosky CEO & President; Director | 15,924 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Stefan K. L. Oh Chief Investment Officer | 97,289 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Stefan K. L. Oh Chief Investment Officer | 95,671 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 2,945,710.09 |
| Apr 8, 2025 | Stefan K. L. Oh Chief Investment Officer | 3,185 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Gabriel M. Willhite Chief Operating Officer | 150,863 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Gabriel M. Willhite Chief Operating Officer | 147,426 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 4,539,246.54 |
| Apr 8, 2025 | Gabriel M. Willhite Chief Operating Officer | 6,768 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Mark E. Foster EVP, GC & Secretary | 63,408 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 8, 2025 | Mark E. Foster EVP, GC & Secretary | 61,891 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.79 per share | 1,905,623.89 |
| Apr 8, 2025 | Mark E. Foster EVP, GC & Secretary | 2,986 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |